AAAshraf I. Ahmed

Ashraf I. Ahmed

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ashraf I. Ahmed has a total of 34 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Solitary gastric juvenile polyp in an adult patient: A rare case report and review of the literature

    by Yousra Ali, Elhassan Mahmoud, Ashraf I. Ahmed, M. Z. Sharaf Eldean, Abdulrahman Al-Janahi, Jinsha Abduljaleel

    Juvenile polyps are benign hamartomatous lesions usually seen in children, most often in the colorectal region. Solitary gastric juvenile polyps in adults without features of polyposis syndromes are exceedingly rare, with fewer than five cases reported in the literature. We describe a 31-year-old male presenting with weight loss and intermittent painless rectal bleeding. Upper endoscopy revealed a solitary pedunculated polyp in the gastric antrum, which was removed via endoscopic mucosal resection. Colonoscopy showed internal hemorrhoids and a solitary rectal ulcer, which were likely the source of bleeding, while small bowel imaging was unremarkable. Histopathology confirmed a juvenile polyp. This case emphasizes the importance of recognizing this rare entity and the role of endoscopy in diagnosis and management.

  • Open Access

    Multiple myeloma presenting with cavernous sinus syndrome: A case report and literature review

    by Yusuf Hallak, Mohamed Malek Soumakieh, Bisher Sawaf, Geiger Matthew, Ahmad BaTheeb, Ashraf I. Ahmed, Nezam Altorok, Mani Askari

    A 68-year-old man presented with progressive left cranial nerve III palsy, initially misattributed to a vascular etiology. Early magnetic resonance imaging revealed a mass in the left cavernous sinus with extensive calvarial lesions. Concurrent serum studies, including serum protein electrophoresis and free light-chain assays, identified hypercalcemia, renal dysfunction, anemia, bone lesions features, and a monoclonal Immunoglobulin A lambda spike, leading to a diagnosis of multiple myeloma with central nervous system involvement manifesting as cavernous sinus syndrome (CSS). The patient responded rapidly to corticosteroids and palliative radiotherapy, followed by systemic chemotherapy. This case illustrates the critical role of early neuroimaging and comprehensive serum studies in diagnosing CSS due to multiple myeloma and emphasizes the need for heightened clinical suspicion when evaluating atypical cranial neuropathies.

  • Open Access

    Diabetic ketoacidosis as the initial presentation of hepatogenous diabetes: a first reported case

    by Mhd Kutaiba Albuni, Shahem Abbarh, Noheir Ashraf Ibrahem Fathy Hassan, Bisher Sawaf, Ashraf I Ahmed, Yusuf Hallak, Muaataz Azzawi

    Summary: Hepatogenous diabetes, a secondary form of diabetes arising from chronic liver disease, particularly cirrhosis, is a well-documented complication. However, diabetic ketoacidosis (DKA) in the context of hepatogenous diabetes has not been reported in the literature. We report the case of a 60-year-old male with alcoholic liver cirrhosis and no prior history of diabetes who presented with altered mental status and was diagnosed with DKA. Initial lab tests revealed severe hyperglycemia, high-anion gap metabolic acidosis, and an elevated HbA1C of 10.2%, a significant increase from 5.2% five months earlier. The patient was managed with insulin and lactulose, resulting in clinical improvement. Follow-up revealed normalization of HbA1C and a reduction in insulin requirements. This is the first documented case of DKA as the initial presentation of hepatogenous diabetes, emphasizing the need for heightened awareness and further research into its clinical manifestations and management. Key clinical messages:


  • Open Access

    Spontaneous Bacterial Peritonitis Beyond the Usual Suspects: Case Series of Salmonella and Brucella With Comprehensive Literature Review

    by Hussam Almasri, Elhassan Mahmoud, Ashraf I. Ahmed, Hamad A. Alkorbi, Aiman Ahmed, Shahem Abbarh, Bisher Sawaf

    While Escherichia coli , Streptococcus , and Klebsiella species traditionally account for most cases of spontaneous bacterial peritonitis (SBP), atypical pathogens can be found. Salmonella , typically known for causing gastroenteritis, rarely manifests as SBP, while Brucella , a zoonotic pathogen, presents a unique challenge in the context of peritoneal infection. In this report, we present two cases of SBP caused by these atypical organisms. The first case involved a 58‐year‐old female with a history of hepatitis C‐related chronic liver disease and cryoglobulinemic vasculitis, who presented with SBP and hepatorenal syndrome‐associated acute kidney injury. Salmonella was identified in both ascitic fluid and blood cultures, but despite appropriate treatment, the patient experienced a fatal deterioration. The second case features a 52‐year‐old male with type 2 diabetes mellitus and newly diagnosed schistosomiasis, who presented with findings of decompensated liver cirrhosis and SBP. Brucella was isolated from ascitic fluid cultures, and the patient responded well to treatment. We aim to highlight the need for early recognition of atypical causes of SBP to improve management and outcomes.


  • Open Access

    Hyperthyroidism‐Induced Nondiabetic Ketoacidosis: A Rare Case Report

    by Elias Battikh, Sherif Mostafa, Hadeel Alfar, Koutaibah Obaid, Ashraf I. Ahmed, Bisher Sawaf, Dabia Al‐Mohanadi

    Hyperthyroidism, marked by excess thyroid hormones (T4 and T3), presents with symptoms like palpitations, heat intolerance, anxiety, and weight loss despite a normal or increased appetite. Diagnosis involves low serum TSH levels and elevated free T4 and/or T3. Rarely, hyperthyroidism can lead to nondiabetic ketoacidosis (NDKA). This report describes a 40‐year‐old woman with palpitations, chest discomfort, heat intolerance, insomnia, and significant weight loss. Laboratory tests showed severely suppressed TSH, elevated free T4 and T3, and high anion gap metabolic acidosis with elevated ketone levels. She was diagnosed with hyperthyroidism‐induced NDKA. Hyperthyroidism can promote lipolysis and ketogenesis, potentially leading to NDKA. Though uncommon, it is essential for clinicians to consider hyperthyroidism in NDKA cases when common causes are excluded. Our patient's symptoms significantly improved with propranolol and carbimazole treatment. This case emphasizes the importance of recognizing hyperthyroidism as a potential cause of NDKA. Appropriate diagnosis and treatment with antithyroid medications can lead to complete symptom resolution and normalization of biochemical markers.


  • Open Access

    Sump syndrome: Diagnosis dilemmas and therapeutic approaches—A case series

    by Shahem Abbarh, Bisher Sawaf, Hussam Almasri, Girisha Balaraju, Mhd Kutaiba Albuni, Shaher Abbarah, Ashraf I. Ahmed, Abdellatif Ismail, Saad Rashid Mohammad Al Kaabi

    Key Clinical Message: It is important to consider the diagnosis of Sump syndrome in patients with a history of open cholecystectomy, particularly in those who migrate from developing countries where alternative biliary interventions may be limited. The presentation may range from acute severe, mimicking acute ascending cholangitis, to chronic recurrent abdominal pain without evidence of inflammation. Management is a case‐by‐case decision, with principal management aims to decompress the biliary tract and address any underlying sepsis. Sump syndrome is a rare and often long‐term complication of choledochoduodenostomy (CDD). The presentation and severity are variable, and management should be tailored to each patient based on several factors. Herein, we report three cases of sump syndrome, each demonstrating unique diagnostic dilemmas and therapeutic modalities. Case I describes a woman presenting with acute cholangitis, managed with percutaneous transhepatic cholangiography (PTC) and endoscopic retrograde cholangiopancreatography (ERCP). Case II illustrates a similar presentation complicated by myocardial infarction, necessitating urgent biliary decompression via PTC and subsequent unsuccessful endoscopic stenting. Case III highlights the diagnostic difficulty in a stable patient with inconclusive diagnostic imaging. This case series emphasizes the importance of considering sump syndrome diagnosis in patients with a history of CDD or open cholecystectomy, especially in elderly patients and those who come from regions where alternative biliary interventions may be limited.


  • Open Access

    Small bowel neuroendocrine tumor presenting with chronic diarrhea and mesenteric ischemia: A case report

    by Bisher Sawaf, Shahem Abbarh, Ashraf I. Ahmed, Malik Halabiya, Abdellatif Ismail, Souraia Mezhoud

    Key Clinical Message: The diagnosis of gastrointestinal neuroendocrine tumors is often challenging owing to the nonspecific presentation. This may lead to delayed diagnosis and serious, rare complications, such as acute mesenteric ischemia. This case highlights the importance of early recognition and the need for a multidisciplinary approach to managing such cases. Gastrointestinal (GI) neuroendocrine tumors (NETs) are rare neoplasms originating from neuroendocrine cells within the digestive tract. Despite their rarity, their incidence is increasing, necessitating a better understanding of their presentation and management. In the present report, we present a case of duodenal bulb NET that caused chronic diarrhea and unintentional weight loss for 2 years before manifesting as acute mesenteric ischemia. This case sheds light on the diagnostic challenges associated with GI NETs, particularly in cases with nonspecific symptoms. In addition, it underscores the importance of prompt recognition and management, as evidenced by the progression of the patient to acute mesenteric ischemia.

  • Open Access

    Terlipressin‐induced skin necrosis in cirrhotic patients—A case report and comprehensive literature review

    by Ashraf I. Ahmed, Muhammad Zain Kaleem, Shahem Abbarh, Haider Hussein Barjas, Abdellatif Ismail, Mhd Kutaiba Albuni, Bisher Sawaf

    Key Clinical Message: The occurrence of terlipressin‐induced skin necrosis in cirrhotic patients is a rare but serious adverse event that warrants further investigation. Clinicians should be aware of this potential complication in cirrhotic patients receiving terlipressin therapy and closely monitor for any signs of skin necrosis. Early recognition and prompt intervention are crucial in preventing further complications and improving patient outcomes. Further research is needed to better understand the risk factors associated with terlipressin‐induced skin necrosis and to develop effective preventive strategies. Overall, healthcare providers should exercise caution when prescribing terlipressin to cirrhotic patients, weighing the potential benefits against the risks of this rare but significant adverse event. Terlipressin is commonly used to manage conditions related to portal hypertension, such as hepatorenal syndrome and esophageal variceal bleeding. Despite its therapeutic benefits, terlipressin can rarely lead to severe ischemic complications involving the skin vasculature, known as terlipressin‐induced skin necrosis. We present a 50‐year‐old male with cirrhosis and acute variceal bleeding who developed skin necrosis following terlipressin administration. We performed a comprehensive review of the literature by analyzing 18 case reports/case series comprising 22 cirrhotic patients with terlipressin‐induced skin necrosis. Among these individuals, we found a mean age of 51 years with a male predominance (78%). Further analysis showed that the onset of skin necrosis ranged from 2 to 5 days post‐terlipressin initiation, with bolus administration being predominant (85.7%). The underlying pathophysiological mechanisms of terlipressin‐induced skin ischemia are still elusive but primarily attributed to the vasoconstrictive and thrombogenic effects. Management involves terlipressin discontinuation and supportive care. Physicians should be aware of this potential complication in patients receiving terlipressin and closely observe for any signs of skin rash.


  • Open Access

    Terlipressin-Induced Skin Necrosis in Cirrhotic Patients - A Case Report and Comprehensive Literature Review

    by Ashraf I. Ahmed, Muhammad Zain Kaleem, Shahem Abbarh, Haidar Barjas, Abdellatif Ismail Ismail, Mhd Kutaiba Albuni, Bisher Sawaf